• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Disopyramide in the prevention of recurrence of atrial fibrillation after electroconversion.

作者信息

Härtel G, Louhija A, Konttinen A

出版信息

Clin Pharmacol Ther. 1974 Jun;15(6):551-5. doi: 10.1002/cpt1974156551.

DOI:10.1002/cpt1974156551
PMID:4601741
Abstract
摘要

相似文献

1
Disopyramide in the prevention of recurrence of atrial fibrillation after electroconversion.丙吡胺用于预防电复律后房颤复发
Clin Pharmacol Ther. 1974 Jun;15(6):551-5. doi: 10.1002/cpt1974156551.
2
Clinical studies of Norpace (Part IV).心律平的临床研究（第四部分）。
Angiology. 1975 Jan;26(1 Pt 2):138-9.
3
Clinical studies of Norpace (Part VIII).
Angiology. 1975 Jan;26(1 Pt 2):144-5.
4
Clinical studies of Norpace. Summarizing remarks.
Angiology. 1975 Jan;26(1 Pt 2):154-5.
5
[Disopyramide in the therapy and prevention of chronic atrial fibrillation. Study of 50 cases].
Minerva Cardioangiol. 1973 Dec 12;21(12):827-32.
6
Clinical studies of Norpace (Part II).
Angiology. 1975 Jan;26(1 Pt 2):132-6.
7
[Disopyramide in the therapy and prevention of chronic atrial fibrillation. Study of 50 cases].
Usp Sovrem Biol. 1973 Jul-Aug;76(4):827-32.
8
[Postoperative treatment of acquired valvular disease with atrial fibrillation with disopyramide--with special reference to prevention of recurrence of atrial fibrillation].[用丙吡胺对伴有心房颤动的后天性瓣膜病进行术后治疗——特别提及预防心房颤动复发]
Kokyu To Junkan. 1982 Nov;30(11):1157-60.
9
[Correction of atrial fibrillation with disopyramide].[丙吡胺治疗心房颤动]
Coeur Med Interne. 1972 Jul-Sep;11(3):581-6.
10
Clinical studies of Norpace (Part VII).
Angiology. 1975 Jan;26(1 Pt 2):143.

引用本文的文献

1
Revisiting Antiarrhythmic Drug Therapy for Atrial Fibrillation: Reviewing Lessons Learned and Redefining Therapeutic Paradigms.重新审视用于心房颤动的抗心律失常药物治疗：回顾经验教训并重新定义治疗模式。
Front Pharmacol. 2020 Nov 9;11:581837. doi: 10.3389/fphar.2020.581837. eCollection 2020.
2
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.心房颤动复律后维持窦性心律的抗心律失常药物。
Cochrane Database Syst Rev. 2019 Sep 4;9(9):CD005049. doi: 10.1002/14651858.CD005049.pub5.
3
Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation.
抗心律失常药物促进心房颤动患者窦性心律有效性的随机对照试验的荟萃分析。
Heart. 2002 Jun;87(6):535-43. doi: 10.1136/heart.87.6.535.
4
Propafenone versus disopyramide for maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation: a randomized, double-blind study. PRODIS Study Group.
Cardiovasc Drugs Ther. 1996 May;10(2):145-52. doi: 10.1007/BF00823592.
5
The treatment of atrial fibrillation. An evaluation of drug therapy, electrical modalities and therapeutic considerations.心房颤动的治疗。药物治疗、电学方法及治疗考量的评估。
Drugs. 1994 Sep;48(3):345-71. doi: 10.2165/00003495-199448030-00003.
6
Plasma concentration of disopyramide given as capsules and controlled release tablets.以胶囊和控释片形式给药的丙吡胺的血浆浓度。
Eur J Clin Pharmacol. 1983;24(2):199-203. doi: 10.1007/BF00613817.
7
Efficacy of disopyramide in conversion and prophylaxis of post-thyrotoxic atrial fibrillation.
Eur J Clin Pharmacol. 1991;40(3):215-9. doi: 10.1007/BF00315198.
8
Antiarrhythmic drug classifications. A critical appraisal of their history, present status, and clinical relevance.抗心律失常药物分类。对其历史、现状及临床相关性的批判性评价。
Drugs. 1991 May;41(5):672-701. doi: 10.2165/00003495-199141050-00002.
9
The pharmacologic treatment of atrial fibrillation.心房颤动的药物治疗
Cardiovasc Drugs Ther. 1991 Jun;5(3):617-28. doi: 10.1007/BF03029730.
10
Pharmacodynamics of the antiarrhythmic disopyramide in healthy humans: correlation of the kinetics of the drug and its effects.
J Pharmacokinet Biopharm. 1976 Jun;4(3):231-42. doi: 10.1007/BF01063615.